Optimization of Timing and Times for Administration of Atorvastatin‐Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction

Our previous studies showed that the combination of atorvastatin (ATV) and single injection of ATV‐pretreated mesenchymal stem cells (MSCs) ((ATV)‐MSCs) at 1 week post‐acute myocardial infarction (AMI) promoted MSC recruitment and survival. This study aimed to investigate whether the combinatorial t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jun, Xiong, Yu‐Yan, Li, Qing, Hu, Meng‐Jin, Huang, Pei‐Sen, Xu, Jun‐Yan, Tian, Xia‐Qiu, Jin, Chen, Liu, Jian‐Dong, Qian, Li, Yang, Yue‐Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Standards, Protocols, Policies, and Regulations for Cell‐Based Therapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766601/
https://www.ncbi.nlm.nih.gov/pubmed/31245934
http://dx.doi.org/10.1002/sctm.19-0013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766601/
https://www.ncbi.nlm.nih.gov/pubmed/31245934
http://dx.doi.org/10.1002/sctm.19-0013

Ejemplares similares